Test Code C1Q Complement C1q, Serum
Additional Codes
| Epic Ordering Code | LAB3041442 |
| NBS code | LBC13308 |
| Service code | 36802 |
Reporting Name
Complement C1q, SSpecimen Type
SerumSpecimen Required
Patient Preparation:
Fasting: 12 hours, preferred but not required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial
NUH Outreach Laboratories:
Specimen Requirements
Submit only one of the following immediately:
Preferred: Gold Top
Acceptable: Red Top
Fasting: 12 hours, preferred but not required
Processing Requirements
Centrifuge and aliquot serum into a plastic vial.
Specimen type: Serum
Volume: 1 mL
Storage/transport requirements: Refrigerated
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 28 days |
| Frozen | 28 days | |
| Ambient | 21 days |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
Method Name
Nephelometry
Day(s) Performed
Monday through Friday
Report Available
2 to 5 daysPlease note that this is a referral test requiring transport to the external testing facility and an additional 3-5 days is required.
Reference Values
12-22 mg/dL
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Assessment of an undetectable total complement level
Diagnosing congenital C1 (first component of complement) deficiency
Diagnosing acquired deficiency of C1 inhibitor
CPT Code Information
86160
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| C1Q | Complement C1q, S | 4478-4 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| C1Q | Complement C1q, S | 4478-4 |
Secondary ID
8851Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Last updated 06/07/2026